344
Views
6
CrossRef citations to date
0
Altmetric
Review

Reviewing Potentially Inappropriate Medication in Hospitalized Patients Over 65 Using Explicit Criteria: A Systematic Literature Review

ORCID Icon, , &
Pages 183-210 | Published online: 03 Nov 2021

References

  • Jensen LD, Andersen O, Hallin M, Petersen J. Potentially inappropriate medication related to weakness in older acute medical patients. Int J Clin Pharm. 2014;36(3):570–580. doi:10.1007/s11096-014-9940-y
  • Renom-Guiteras A, Thürmann PA, Miralles R, et al. Potentially inappropriate medication among people with dementia in eight European countries. Age Ageing. 2018;47(1):68–74. doi:10.1093/ageing/afx147
  • Morgan SG, Hunt J, Rioux J, Proulx J, Weymann D, Tannenbaum C. Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study. CMAJ Open. 2016;4(2):E346–E351. doi:10.9778/cmajo.20150131
  • Harrison SL, Kouladjian O’Donnell L, Milte R, et al. Costs of potentially inappropriate medication use in residential aged care facilities. BMC Geriatr. 2018;18(1):9. doi:10.1186/s12877-018-0704-8
  • Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–2724. doi:10.1001/archinte.163.22.2716
  • Piau A, Huet Y, Gallini A, Andre L, Vellas B, Nourhashemi F. Optimization of drug therapy in elderly individuals admitted to a geriatric unit. Clin Interv Aging. 2017;12:1691–1696. doi:10.2147/CIA.S132309
  • Goodwin MA, Stange KC, Zyzanski SJ, Crabtree BF, Borawski EA, Flocke SA. The Hawthorne effect in direct observation research with physicians and patients. J Eval Clin Pract. 2017;23(6):1322–1328. doi:10.1111/jep.12781
  • Laroche ML, Charmes JP, Nouaille Y, Fourrier A, Merle L. Impact of hospitalisation in an acute medical geriatric unit on potentially inappropriate medication use. Drugs Aging. 2006;23(1):49–59. doi:10.2165/00002512-200623010-00005
  • Onatade R, Auyeung V, Scutt G, Fernando J. Potentially inappropriate prescribing in patients on admission and discharge from an older peoples’ unit of an acute UK hospital. Drugs Aging. 2013;30(9):729–737. doi:10.1007/s40266-013-0097-5
  • Komagamine J. Prevalence of potentially inappropriate medications at admission and discharge among hospitalised elderly patients with acute medical illness at a single centre in Japan: a retrospective cross-sectional study. BMJ Open. 2018;8(7):e021152. doi:10.1136/bmjopen-2017-021152
  • Dos Santos NS, Marengo LL, Moraes FDS, Barberato-Filho S. Interventions to reduce the prescription of inappropriate medicines in older patients. Rev Saúde Pública. 2019;53:7.
  • Sallevelt BTGM, Huibers CJA, Knol W, van Puijenbroek E, Egberts T, Wilting I. Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study. BMJ Open. 2020;10(2):e033721. doi:10.1136/bmjopen-2019-033721
  • By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS Beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.15767
  • O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218. doi:10.1093/ageing/afu145
  • Motter FR, Fritzen JS, Hilmer SN, Paniz ÉV, Paniz VMV. Potentially inappropriate medication in the elderly: a systematic review of validated explicit criteria. Eur J Clin Pharmacol. 2018;74(6):679–700. doi:10.1007/s00228-018-2446-0
  • Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions. England: Wiley-Blackwell; 2008.
  • Hong QN, Pluye P, Fàbregues S, et al. Mixed methods appraisal tool (MMAT), version 2018. Canada: IC Canadian Intellectual Property Office; 2018.
  • Hong QN, Fàbregues S, Bartlett G, et al. The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Educ Inf. 2018;34(4):285–291. doi:10.3233/EFI-180221
  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2017 Mar 29;372–n71.
  • Cossette B, Éthier J-F, Joly-Mischlich T, et al. Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial. Eur J Clin Pharmacol. 2017;73(10):1237–1245. doi:10.1007/s00228-017-2293-4
  • Dalleur O, Boland B, Losseau C, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291–298. doi:10.1007/s40266-014-0157-5
  • Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–854. doi:10.1038/clpt.2011.44
  • Michalek C, Wehling M, Schlitzer J, Frohnhofen H. Effects of ‘Fit fOR The Aged’ (FORTA) on pharmacotherapy and clinical endpoints–a pilot randomized controlled study. Eur J Clin Pharmacol. 2014;70(10):1261–1267. doi:10.1007/s00228-014-1731-9
  • Spinewine A, Swine C, Dhillon S, et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55(5):658–665.
  • Wehling M, Burkhardt H, Kuhn-Thiel A, et al. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing. 2016;45(2):262–267. doi:10.1093/ageing/afv200
  • der Linden LV, Decoutere L, Walgraeve K, et al. Combined use of the rationalization of home medication by an adjusted STOPP in older patients (RASP) list and a pharmacist-led medication review in very old inpatients: impact on quality of prescribing and clinical outcome. Drugs Aging. 2016;2(34):123–133.
  • Lozano-Montoya I, Vélez-Diaz-Pallarés M, Delgado-Silveira E, Montero-Errasquin B, Cruz Jentoft AJ. Potentially inappropriate prescribing detected by STOPP–START criteria: are they really inappropriate? Age Ageing. 2015;44(5):861–866. doi:10.1093/ageing/afv079
  • Mattison MLP, Afonso KA, Ngo LH, Mukamal KJ. Preventing potentially inappropriate medication use in hospitalized older patients with a computerized provider order entry warning system. Arch Intern Med. 2010;170(15):1331–1336. doi:10.1001/archinternmed.2010.244
  • Urfer M, Elzi L, Dell-Kuster S, Bassetti S. Intervention to improve appropriate prescribing and reduce polypharmacy in elderly patients admitted to an internal medicine unit. PLoS One. 2016;11(11):e0166359. doi:10.1371/journal.pone.0166359
  • Xuan Vu T, Bui Thi Huong Q. The effect of the pharmacist’s intervention on potentially inappropriate medication use in older adults using the 2015 Beers criteria. Pharm Sci Asia. 2019;46(1):54–61. doi:10.29090/psa.2019.01.017.0023
  • Abbasinazari M, Tavana A. Identification and acceptance of suggested therapeutic alternatives of potentially inappropriate medications amongst hospitalised geriatric patients in Iran. J Pharm Pract Res. 2020;50(1):75–77. doi:10.1002/jppr.1583
  • Darmawan E, Ahmad H, Perwitasari DA, Kusumawardani N. Pharmacist intervention can reduce the potential use of inappropriate drugs medications in Indonesian geriatric patients. J App Pharm Sci. 2020;10(1):88–95.
  • Hannou S, Voirol P, Pannatier A, et al. Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry. Int J Clin Pharm. 2017;39(6):1228–1236. doi:10.1007/s11096-017-0513-8
  • Lang PO, Vogt-Ferrier N, Hasso Y, et al. Interdisciplinary geriatric and psychiatric care reduces potentially inappropriate prescribing in the hospital: interventional study in 150 acutely ill elderly patients with mental and somatic comorbid conditions. J Am Med Dir Assoc. 2012;13(4):406.e1–406.e7. doi:10.1016/j.jamda.2011.03.008
  • O’Sullivan D, O’Mahony D, O’Connor MN, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31(6):471–481. doi:10.1007/s40266-014-0172-6
  • Alosaimy S, Vaidya A, Day K, Stern G. Effect of a pharmacist-driven medication management intervention among older adults in an inpatient setting. Drugs Aging. 2019;36(4):371–378. doi:10.1007/s40266-018-00634-9
  • Chandrasekhar D, Samjas M, Pattani D. Evaluation of potentially inappropriate medications among hospitalized geriatric patients in tertiary care referral hospital using STOPP/START criteria. Clin Epidemiol Glob Health. 2018. Available from http://www.sciencedirect.com/science/article/pii/S2213398418300216. Accessed October 15, 2021.
  • Chu LL, Su HC, Wang HY. Construct a CPOE decision supporting and monitoring system to decrease PIMS used in hospitalized elderly patients. Value Health. 2014;17(7):A754–A755. doi:10.1016/j.jval.2014.08.220
  • Kadri B, Tritz T, Lecoeur A, Mercier FL, Cudennec T. CP-030 assessment of medical care for older patients in an acute geriatric department with the stopp/start criteria. Eur J Hosp Pharm. 2017;24(Suppl 1):A13.
  • Kimura T, Ogura F, Kukita Y, et al. Efficacy of pharmacists’ assessment and intervention based on Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese compared with Screening Tool of Older Persons’ potentially inappropriate prescriptions criteria version 2 in older patients with cardiovascular disease. Geriatr Gerontol Int. 2019;19(11):1101–1107.
  • Kympers C, Tommelein E, Van Leeuwen E, Boussery K, Petrovic M, Somers A. Detection of potentially inappropriate prescribing in older patients with the GheOP3S-tool: completeness and clinical relevance. Acta Clin Belg. 2019;74:126–136.
  • Pandraud-Riguet I, Bonnet-Zamponi D, Bourcier E, et al. Monitoring of potentially inappropriate prescriptions in older inpatients: a French multicenter study. J Am Geriatr Soc. 2017;65(12):2713–2719. doi:10.1111/jgs.15081
  • Brown B, Earnhart J. Pharmacists and their effectiveness in ensuring the appropriateness of the chronic medication regimens of geriatric inpatients [Internet]. 2004 [ cited April 2, 2019]. Available from: https://www.ingentaconnect.com/content/ascp/tcp/2004/00000019/00000005/art00003. Accessed October 15, 2021.
  • Cossette B, Bergeron J, Ricard G, et al. Knowledge translation strategy to reduce the use of potentially inappropriate medications in hospitalized elderly adults. J Am Geriatr Soc. 2016;64(12):2487–2494. doi:10.1111/jgs.14322
  • Ghibelli S, Marengoni A, Djade CD, et al. Prevention of inappropriate prescribing in hospitalized older patients using a computerized prescription support system (INTERcheck(®)). Drugs Aging. 2013;30(10):821–828. doi:10.1007/s40266-013-0109-5
  • Kersten H, Hvidsten LT, Gløersen G, Wyller TB, Wang-Hansen MS. Clinical impact of potentially inappropriate medications during hospitalization of acutely ill older patients with multimorbidity. Scand J Prim Health Care. 2015;33(4):243–251. doi:10.3109/02813432.2015.1084766
  • Sennesael A-L, Dalleur O, Henrard S, Artoisenet C, Schoevaerdts D, Spinewine A. Implementing a screening tool to improve prescribing in hospitalized older patients: a pilot study. Int J Clin Pharm. 2018;40(1):15–19. doi:10.1007/s11096-017-0563-y
  • Boland B, Guignard B, Dalleur O, Lang PO. Application of STOPP/START and Beers criteria: compared analysis on identification and relevance of potentially inappropriate prescriptions. 2016 [ cited April 2, 2019]; Available from: https://www.sciencedirect.com/science/article/pii/S1878764916300286. Accessed October 15, 2021.
  • Henschel F, Redaelli M, Siegel M, Stock S. Correlation of incident potentially inappropriate medication prescriptions and hospitalization: an analysis based on the PRISCUS list. Drugs Real World Outcomes. 2015;2(3):249–259. doi:10.1007/s40801-015-0035-4
  • Ní Chróinín D, Neto HM, Xiao D, et al. Potentially inappropriate medications (PIMs) in older hospital in-patients: prevalence, contribution to hospital admission and documentation of rationale for continuation. Australas J Ageing. 2016;35(4):262–265. doi:10.1111/ajag.12312
  • Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study. BMJ. 2018;363:k4524. doi:10.1136/bmj.k4524
  • Rothberg MB, Pekow PS, Liu F, et al. Potentially inappropriate medication use in hospitalized elders. J Hosp Med. 2008;Mar(2):91–102. doi:10.1002/jhm.290
  • Scott S, Twigg MJ, Clark A, et al. Development of a hospital deprescribing implementation framework: a focus group study with geriatricians and pharmacists. Age Ageing. 2020;49(1):102–110. doi:10.1093/ageing/afz133
  • Marvin V, Ward E, Poots AJ, Heard K, Rajagopalan A, Jubraj B. Deprescribing medicines in the acute setting to reduce the risk of falls. Eur J Hosp Pharm. 2017;24(1):10–15. doi:10.1136/ejhpharm-2016-001003
  • Gazarin M, Devin B, Tse D, et al. Evaluating an inpatient deprescribing initiative at a rural community hospital in Ontario. Can Pharm J. 2020;153(4):224–231. doi:10.1177/1715163520929734
  • Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians’ views on deprescribing in everyday practice. Ann Fam Med. 2017;15(4):341–346. doi:10.1370/afm.2094
  • Thomas RE, Thomas BC. A systematic review of studies of the STOPP/START 2015 and American geriatric society Beers 2015 criteria in patients ≥ 65 years. Curr Aging Sci. 2019;12(2):121–154. doi:10.2174/1874609812666190516093742
  • Al Shemeili S, Klein S, Strath A, Fares S, Stewart D. An exploration of health professionals’ experiences of medicines management in elderly, hospitalised patients in Abu Dhabi. Int J Clin Pharm. 2016;38(1):107–118. doi:10.1007/s11096-015-0212-2
  • Cullinan S, Fleming A, O’Mahony D, et al. Doctors’ perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol. 2015;79(5):860–869. doi:10.1111/bcp.12555
  • Manias E. Effects of interdisciplinary collaboration in hospitals on medication errors: an integrative review. Expert Opin Drug Saf. 2018;17(3):259–275. doi:10.1080/14740338.2018.1424830
  • Spinewine A, Swine C, Dhillon S, et al. Appropriateness of use of medicines in elderly inpatients: qualitative study. BMJ. 2005;331(7522):935. doi:10.1136/bmj.38551.410012.06
  • Ferner RE, Aronson JK. Medication errors, worse than a crime. Lancet. 2000;355(9208):947–948. doi:10.1016/S0140-6736(00)99025-1
  • McDonald J, Jayasuriya R, Harris MF. The influence of power dynamics and trust on multidisciplinary collaboration: a qualitative case study of type 2 diabetes mellitus. BMC Health Serv Res. 2012;12(1):63. doi:10.1186/1472-6963-12-63
  • Chui MA, Stone JA, Odukoya OK, Maxwell L. Facilitating collaboration between pharmacists and physicians using an iterative interview process. J Am Pharm Assoc. 2014;54(1):35–41. doi:10.1331/JAPhA.2014.13104
  • Goyal P, Requijo T, Siceloff B, et al. Patient-reported barriers and facilitators to deprescribing cardiovascular medications. Drugs Aging. 2020;37(2):125–135. doi:10.1007/s40266-019-00729-x
  • Reeve E, Low L-F, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–e560. doi:10.3399/bjgp16X685669
  • Zechmann S, Trueb C, Valeri F, Streit S, Senn O, Neuner-Jehle S. Barriers and enablers for deprescribing among older, multimorbid patients with polypharmacy: an explorative study from Switzerland. BMC Fam Pract. 2019;20(1):64. doi:10.1186/s12875-019-0953-4
  • Luymes CH, van der Kleij RMJJ, Poortvliet RKE, de Ruijter W, Reis R, Numans ME. Deprescribing potentially inappropriate preventive cardiovascular medication: barriers and enablers for patients and general practitioners. Ann Pharmacother. 2016;50(6):446–454. doi:10.1177/1060028016637181
  • Vermeir P, Vandijck D, Degroote S, et al. Communication in healthcare: a narrative review of the literature and practical recommendations. Int J Clin Pract. 2015;69(11):1257–1267. doi:10.1111/ijcp.12686
  • Weetman K, Dale J, Spencer R, Scott E, Schnurr S. GP perspectives on hospital discharge letters: an interview and focus group study. BJGP Open. 2020;4(2):bjgpopen20X101031. doi:10.3399/bjgpopen20X101031
  • Wills M, Hyland L, Chearman T, Cross F, Verrier-Jones K. GP and hospital doctor perspectives on the hospital patient discharge process. Bull Royal Coll Surg Engl. 2011;93(1):1–4. doi:10.1308/147363511X546518
  • Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831–841. doi:10.1001/jama.297.8.831
  • Hill‐Taylor B, Sketris I, Hayden J, Byrne S, O’Sullivan D, Christie R. Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact. J Clin Pharm Ther. 2013;38(5):360–372. doi:10.1111/jcpt.12059
  • Ferrill MJ, Brown DA, Kyle JA. Clinical versus statistical significance: interpreting P values and confidence intervals related to measures of association to guide decision making. J Pharm Pract. 2010;23(4):344–351. doi:10.1177/0897190009358774
  • Page P. Beyond statistical significance: clinical interpretation of rehabilitation research literature. Int J Sports Phys Ther. 2014;9(5):726–736.